Lipodystrophysyndrome associated with antiretroviral therapy in HIV patients: Considerations for psychosocial aspects;Sindrome dalipodi strofi aassoci ada com a terapia anti-retroviral em portadores do HIV: Consi derações para os aspectos psi cossociai S

Revista Latino-Americana de Enfermagem

Volumn 15, Issue 5, 2007, Pages 1041-1045

  Fernandes, Ana Paula Morais ^a   Sanches, Roberta Seron ^a   Mill, Judy ^b   Lucy, Daniel ^b   Palha, Pedro Fredemir ^a   Dalri, Maria Célia Sarcellos ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acquired immunodeficiency syndrome; HIV; Lipodystrophy; Nursing

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; PSYCHOLOGY; QUALITY OF LIFE;

ANTI-RETROVIRAL AGENTS; HIV INFECTIONS; HUMANS; LIPODYSTROPHY; PSYCHOLOGY; QUALITY OF LIFE;

EID: 38849184045     PISSN: 01041169     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-11692007000500024     Document Type: Article

References (18)

1. Viraben R, Aquilina C. Indinavir-associated lipodystrophy. AIDS 1998; 16:37-9.
2. Carr A, Samaras K, Chisholm DJ, Cooper DA. Abnormal fat distribution and use of protease inhibitors. Lancet 1998; 351: 1736.
3. Kotler DP. HIV lipodystrophy etiology and pathogenesis. Body composition and metabolic alterations: etiology and pathogenesis. AIDS Read 2003; 13:5-9.
4. Amassari A, Antinori A, Cozzi-Lepri A, Trotta MP, Nasti G, Ridolfo AL et al. Relationship between HAART adherence and adipose tissue alterations. Journal of Acquired Immune Deficiency Syndromes 2002; 31: 140-4.
5. Collins E, Wagner C, Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Read 2000; 10: 546-50.
6. Power R, Tate HL, McGilI SM, Taylor C. A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sexually Transmitted Infections 2003; 79: 137-41.
7. Oette M, Juretzko R Kroidl A, Sagir A, Wettstein M, Siegrist J et al. Lypodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patients. AIDS Patient Care and STDs 2002; 16: 413-7.
8. Jenuwine ES, Floyd JA. Comparison of Medical Subject Headings and text-word searches in MEDLINE to retrieve studies on sleep in healthy individuals. J Med Libr Assoc 2004; 92: 349-53.
9. Blanch J, Rousaud A, Martinez E, De Lazzari E, Peri JM, Milinkovic A, et al. Impact of lipodystrophy on the quality of life of HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndromes 2002; 31:404-7.
10. James J, Carruthers A, Carruthers J. HIV-associated lipoatrophy. Dermatologic Surgery 2002; 28: 979-86.
11. Mauss S, Corzillius M, Wolf E, Schwenk A, Adam A, Jaeger H et al. Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patient after 3 years of antiretroviral treatment. HIV Medicine 2002; 3: 49-55.
12. Carr A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS 2003; 17: 141-8.
13. Healthy Minister (BR). Available from: http:// www.aids.gov.br/final/ tratamento/politicas/medicamentos.htm. Access in 21 January 2005.
14. Dreezen C, Schrooten W, de Mey I, Goebel FD, Dedes N, Florence E et al. Self-reported signs of lipodystrophy by persons living with HIV infection. International Journal of STD & AIDS 2002; 13: 393-8.
15. Paton NI, Earnest A, Ng YM, Karim F, Aboulhab J. Lipodystrophy in a cohort of human immunodeficiency virus-infected Asian patient: prevalence, associated factors, and psychological impact. Clinical Infectious Diseases 2002; 35: 1244-9.
16. Corless IB, Nicholas PK, McGibbon CA, Wilson C. Weight change, body image, and quality of life in HIV disease: A pilot study. Applied Nursing Research 2004; 17: 292-296.
17. Tate H, George R. The effect of weight loss on body image in HIV positive gay men. AIDS Care 2001; 13: 163-9.
18. Galvao MTG, Paiva SS, Sawada NO, Pagliuca LMF. Analysis of proxemic communication with HIV/AIDS patients. Rev. Latino-am Enfermagem 2006 July-August, 14(4):491-6.